Burton B Yang Selected Research

Versicans (Versican)

5/2013	The role of versican in modulating breast cancer cell self-renewal.
3/2013	Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity.
8/2012	The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
1/2011	Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.
11/2010	Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.
10/2010	Expression of versican 3'-untranslated region modulates endogenous microRNA functions.
5/2007	The ability of versican to simultaneously cause apoptotic resistance and sensitivity.
7/2006	Versican G3 domain regulates neurite growth and synaptic transmission of hippocampal neurons by activation of epidermal growth factor receptor.
3/2006	Versican G3 domain promotes blood coagulation through suppressing the activity of tissue factor pathway inhibitor-1.
5/2004	Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and beta1-integrin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Burton B Yang Research Topics

Disease

65	Neoplasms (Cancer) 06/2022 - 04/2002
24	Breast Neoplasms (Breast Cancer) 03/2022 - 10/2010
11	Carcinogenesis 01/2021 - 05/2004
7	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2010
5	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 11/2008
4	Astrocytoma (Pilocytic Astrocytoma) 07/2006 - 09/2002
3	Cardiomyopathies (Cardiomyopathy) 06/2022 - 01/2017
3	Fibrosis (Cirrhosis) 06/2022 - 09/2020
3	Infections 01/2021 - 01/2016
3	Body Weight (Weight, Body) 01/2020 - 10/2015
3	Wounds and Injuries (Trauma) 01/2020 - 05/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 08/2019
3	Ovarian Epithelial Carcinoma 01/2018 - 11/2004
3	Inflammation (Inflammations) 01/2018 - 01/2011
3	Hepatocellular Carcinoma (Hepatoma) 06/2016 - 03/2013
3	Hypoxia (Hypoxemia) 01/2014 - 12/2006
2	Heart Failure 06/2022 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 06/2015
2	Carcinoma (Carcinomatosis) 12/2013 - 02/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2012 - 07/2011
1	Exanthema (Rash) 06/2022
1	Alopecia (Baldness) 06/2022
1	Vomiting 06/2022
1	Ascites 03/2022
1	Disease Progression 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2021
1	Herpes Simplex 01/2021
1	Herpesviridae Infections (Herpesvirus Infection) 01/2021
1	Epstein-Barr Virus Infections 01/2021
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2021
1	Coronavirus Infections 01/2021
1	Cardiomegaly (Heart Hypertrophy) 01/2021
1	Hepatitis B 01/2021
1	Gastroenteritis 01/2021
1	Contagious Ecthyma 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Cytomegalovirus Infections (Inclusion Disease) 01/2021
1	Hypertrophy 09/2020
1	Pathologic Processes 09/2020
1	Burns 01/2020

Drug/Important Bio-Agent (IBA)

28	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2006
25	Circular RNAIBA 06/2022 - 01/2016
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2002
12	Versicans (Versican)IBA 05/2013 - 04/2002
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2013
5	IntegrinsIBA 03/2022 - 04/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022 - 01/2011
4	Biological ProductsIBA 01/2022 - 01/2013
4	Messenger RNA (mRNA)IBA 01/2021 - 05/2007
4	ergosterol-5,8-peroxideIBA 01/2017 - 01/2012
4	Activin Receptors (Activin Receptor)IBA 11/2012 - 11/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 04/2004
3	Fibronectins (Fibronectin)IBA 12/2013 - 04/2004
3	ErbB Receptors (EGF Receptor)IBA 03/2013 - 05/2004
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2011 - 11/2004
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2016
2	Caspase 3 (Caspase-3)IBA 01/2020 - 12/2007
2	Hormones (Hormone)IBA 01/2020 - 11/2004
2	Ethanol (Ethyl Alcohol)IBA 01/2020 - 11/2019
2	Insulin (Novolin)FDA Link 01/2020 - 10/2015
2	ethyl acetateIBA 01/2020 - 11/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
2	Apoptosis Regulatory ProteinsIBA 12/2019 - 06/2016
2	Long Noncoding RNAIBA 12/2019 - 03/2019
2	RNA (Ribonucleic Acid)IBA 01/2018 - 12/2007
2	Oxygen (Dioxygen)IBA 01/2018 - 12/2012
2	CurcuminIBA 01/2017 - 10/2015
2	VaccinesIBA 01/2016 - 01/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2015 - 07/2015
2	Pharmaceutical PreparationsIBA 07/2013 - 12/2012
2	CytokinesIBA 06/2013 - 01/2011
2	Small Interfering RNA (siRNA)IBA 05/2013 - 01/2013
2	Epidermal Growth Factor (EGF)IBA 03/2013 - 08/2012
2	VimentinIBA 03/2013 - 01/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2012 - 11/2004
2	3' Untranslated Regions (3' UTR)IBA 04/2012 - 10/2010
2	Cisplatin (Platino)FDA LinkGeneric 05/2011 - 02/2011
2	Docetaxel (Taxotere)FDA Link 04/2011 - 01/2011
2	Proteoglycans (Proteoglycan)IBA 05/2007 - 04/2004
1	Actins (F Actin)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Caspase 9IBA 01/2020
1	fibroblast growth factor 21IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	EnzymesIBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	SolventsIBA 01/2020
1	16S Ribosomal RNAIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	cyanidin-3-O-beta-glucopyranosideIBA 01/2020
1	Dynamin IIBA 12/2019
1	Apolipoproteins E (ApoE)IBA 12/2019

Therapy/Procedure

14	Therapeutics 06/2022 - 04/2004
6	Drug Therapy (Chemotherapy) 12/2019 - 01/2011
1	Precision Medicine 01/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020